A significant breakthrough in cancer research is arising with the use of nanobodies to re-engage dysfunctional p53. This vital malignant suppressor protein is frequently inactivated in many kinds of cancer, resulting https://livebackpage.com/story7477726/vhh-fragments-reactivate-the-p53-protein-a-promising-approach-for-tumor-management